Sign inGet started

Bhanji Muna

Insider CIK 1846905 · CYTK Director · VCYT Director · ARDX Director · NTLA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VCYT VERACYTE, INC. S Sale2026-10-192026-10-201,864$43.70 $81.5K40,854SEC↗
VCYT VERACYTE, INC. S Sale2026-09-012026-09-031,864$42.97 $80.1K42,718SEC↗
VCYT VERACYTE, INC. S Sale2026-09-012026-09-031,864$42.97 $80.1K42,718SEC↗
ARDX ARDELYX, INC. A Award deriv2026-06-162026-06-1839,715— $039,715SEC↗
ARDX ARDELYX, INC. A Award2026-06-162026-06-1826,455— $0163,808SEC↗
VCYT VERACYTE, INC. A Award2026-06-112026-06-155,272— $044,582SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2026-06-092026-06-1013,300— $013,300SEC↗
NTLA Intellia Therapeutics, Inc A Award2026-06-092026-06-109,200— $036,403SEC↗
CYTK CYTOKINETICS INC A Award deriv2026-05-272026-05-274,301— $04,301SEC↗
CYTK CYTOKINETICS INC A Award2026-05-272026-05-272,851— $026,361SEC↗
ARDX ARDELYX, INC. A Award deriv2025-06-182025-06-2354,059— $054,059SEC↗
VCYT VERACYTE, INC. A Award2025-06-182025-06-239,321— $039,310SEC↗
ARDX ARDELYX, INC. A Award2025-06-182025-06-2341,551— $0137,353SEC↗
VCYT VERACYTE, INC. S Sale2025-06-132025-06-174,589$26.67 $122.4K29,989SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2025-06-112025-06-1311,450— $011,450SEC↗
NTLA Intellia Therapeutics, Inc A Award2025-06-112025-06-138,000— $027,203SEC↗
CYTK CYTOKINETICS INC S Sale2025-05-152025-05-151,454$29.73 $43.2K23,510SEC↗
CYTK CYTOKINETICS INC A Award deriv2025-05-142025-05-1410,880— $010,880SEC↗
CYTK CYTOKINETICS INC A Award2025-05-142025-05-147,333— $024,964SEC↗
NTLA Intellia Therapeutics, Inc S Sale2025-04-292025-05-01265$8.50 $2.3K19,203SEC↗
NTLA Intellia Therapeutics, Inc S Sale2025-01-292025-01-31265$9.97 $2.6K19,468SEC↗
ARDX ARDELYX, INC. A Award deriv2024-06-142024-06-1740,243— $040,243SEC↗
VCYT VERACYTE, INC. A Award2024-06-132024-06-1711,473— $034,578SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2024-06-122024-06-1411,515— $011,515SEC↗
NTLA Intellia Therapeutics, Inc A Award2024-06-122024-06-147,737— $019,733SEC↗
CYTK CYTOKINETICS INC S Sale2024-06-102024-06-102,000$52.07 $104.1K17,631SEC↗
VCYT VERACYTE, INC. S Sale2024-06-102024-06-113,870$20.32 $78.6K23,105SEC↗
VCYT VERACYTE, INC. S Sale2024-05-282024-05-301,539$21.00 $32.3K26,975SEC↗
CYTK CYTOKINETICS INC A Award deriv2024-05-152024-05-163,636— $03,636SEC↗
CYTK CYTOKINETICS INC A Award2024-05-152024-05-165,600— $019,631SEC↗
NTLA Intellia Therapeutics, Inc S Sale2023-10-312023-11-02265$23.90 $6.3K11,996SEC↗
NTLA Intellia Therapeutics, Inc S Sale2023-07-312023-08-02265$42.33 $11.2K12,261SEC↗
CYTK CYTOKINETICS INC S Sale2023-07-072023-07-072,000$34.12 $68.2K14,031SEC↗
NTLA Intellia Therapeutics, Inc S Sale2023-07-062023-07-101,867$39.30 $73.4K12,526SEC↗
VCYT VERACYTE, INC. S Sale2023-06-162023-06-215,793$26.42 $153.1K28,614SEC↗
VCYT VERACYTE, INC. S Sale2023-06-162023-06-21100$27.09 $2.7K28,514SEC↗
ARDX ARDELYX, INC. A Award deriv2023-06-152023-06-1649,237— $049,237SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2023-06-142023-06-166,473— $06,473SEC↗
NTLA Intellia Therapeutics, Inc A Award2023-06-142023-06-164,425— $014,393SEC↗
VCYT VERACYTE, INC. A Award2023-06-092023-06-139,674— $034,407SEC↗
VCYT VERACYTE, INC. S Sale2023-05-302023-06-011,539$25.91 $39.9K24,733SEC↗
CYTK CYTOKINETICS INC A Award deriv2023-05-102023-05-1810,000— $010,000SEC↗
CYTK CYTOKINETICS INC A Award2023-05-102023-05-185,000— $016,031SEC↗
CYTK CYTOKINETICS INC A Award2022-10-032022-10-05220$51.11 $11.2K11,031SEC↗
CYTK CYTOKINETICS INC A Award2022-07-012022-07-12274$41.00 $11.2K10,811SEC↗
VCYT VERACYTE, INC. A Award2022-06-162022-06-1614,731— $026,272SEC↗
ARDX ARDELYX, INC. A Award deriv2022-06-152022-06-17100,000— $0100,000SEC↗
ARDX ARDELYX, INC. A Award2022-06-152022-06-1795,802— $095,802SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2022-06-142022-06-162,980— $02,980SEC↗
NTLA Intellia Therapeutics, Inc A Award2022-06-142022-06-162,014— $09,968SEC↗
CYTK CYTOKINETICS INC A Award deriv2022-05-102022-05-1110,000— $010,000SEC↗
CYTK CYTOKINETICS INC A Award2022-05-102022-05-115,000— $010,537SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2022-04-282022-05-0211,700— $011,700SEC↗
NTLA Intellia Therapeutics, Inc A Award2022-04-282022-05-027,954— $07,954SEC↗
CYTK CYTOKINETICS INC A Award2022-04-012022-04-01293$38.38 $11.2K5,537SEC↗
CYTK CYTOKINETICS INC A Award2022-01-032022-01-04244$46.00 $11.2K5,244SEC↗
CYTK CYTOKINETICS INC A Award deriv2021-05-122021-05-1310,000— $010,000SEC↗
CYTK CYTOKINETICS INC A Award2021-05-122021-05-135,000— $05,000SEC↗
VCYT VERACYTE, INC. A Award2021-03-192021-03-2311,541— $011,541SEC↗
ARDX ARDELYX, INC. A Award deriv2021-03-112021-03-1563,687— $063,687SEC↗
CYTK CYTOKINETICS INC A Award deriv2021-02-172021-02-1835,000$21.86 $765.1K35,000SEC↗